Rtw Investments Reduces $7M in Beta Bionics, Inc. ($BBNX)
Rtw Investments trimmed its holdings in BBNX by 500,000 shares, reflecting a 20% decrease.
Key Points
- Rtw Investments cut its position in BBNX by 500,000 shares, reducing its stake to 2 million shares as of May 15, 2026.
- BBNX shares are trading at $14.53, with significant institutional activity from peers like Eventide Asset Management and Soleus Capital Management.
- Analysts such as Goldman Sachs and B of A Securities have maintained their ratings, with price targets ranging from $11 to $24.
Rtw Investments has cut its position in BBNX, reducing its holdings by 500,000 shares. This represents a 20% decrease, bringing its total stake down to 2 million shares. As of the latest filing on May 15, 2026, these shares are valued at approximately $29.06 million.
What Changed in Rtw Investments's BBNX Position
Rtw Investments reduced its stake in BBNX by 500,000 shares, marking a 20% decrease from its previous holding of 2.5 million shares. The firm's new position stands at 2 million shares, valued at about $29.06 million.
Other Institutional Activity in BBNX
Several other institutional investors have also adjusted their positions in BBNX. Eventide Asset Management increased its holdings by 950,760 shares, ending with 5,945,488 shares worth around $59.57 million. Soleus Capital Management made a substantial addition of 1,819,936 shares, bringing its total to 4,354,501 shares valued at $43.63 million. Morgan Stanley added 768,181 shares, resulting in a total of 4,227,634 shares valued at $42.36 million. Meanwhile, Farallon Capital Management reduced its stake by 706,000 shares, leaving it with 3,607,920 shares valued at $36.15 million.
BBNX Stock Snapshot
BBNX shares are currently trading at $14.53. The company has a market cap and other financial metrics that were not specified. The stock's trading activity shows a 52-week range and moving averages that were not detailed in the available data.
Analysts Set New Price Targets
Analysts have maintained their ratings on BBNX. On May 27, 2026, Goldman Sachs maintained a 'buy' rating with a price target of $17. B of A Securities on May 18, 2026, kept a 'hold' rating with a target of $11. Earlier in April, Leerink Partners and Stifel both reaffirmed 'buy' ratings with targets of $24 and $20, respectively. The consensus among analysts suggests a varied outlook with price targets ranging from $11 to $24.
About BBNX
BBNX operates in a sector that was not detailed in the available data. The company is involved in activities that were not specified, and it is headquartered in an undisclosed location. Further information about its CEO, employee count, and specific operations were not provided.
Bottom Line
Rtw Investments' decision to cut its stake in BBNX by 20% is part of a broader trend of institutional adjustments in the company. While BBNX's stock is currently trading at $14.53, analysts have maintained a range of ratings, reflecting varied expectations for the stock's future performance. Investors often track these filings to gauge institutional sentiment, although it's important to remember that 13F filings reflect past positions and may not indicate current holdings.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.